Cardiol Therapeutics
CRDL • NASDAQ
Cardiol Therapeutics is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO David G. Elsley, with a market cap of $107.2M.
CEODavid G. Elsley
Market Cap$107.2M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees17.0
Websitecardiolrx.com
Next Earnings
Upcoming earnings announcement for Cardiol Therapeutics
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.09
Earnings History
Past 12 earnings reports for Cardiol Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.09Est: -$0.09 | 0.0% | - | — | — |
| Aug 14, 2025 | Q2 2025 | -$0.07Est: -$0.10 | +28.0% | - | — | — |
| May 14, 2025 | Q1 2025 | -$0.07 | — | - | — | — |
| Mar 31, 2025 | Q4 2024 | -$0.07Est: -$0.08 | +12.5% | - | — | — |
| Nov 14, 2024 | Q3 2024 | -$0.13Est: -$0.09 | -44.4% | - | — | — |
| Aug 12, 2024 | Q2 2024 | -$0.07Est: -$0.09 | +18.9% | - | — | — |
| May 14, 2024 | Q1 2024 | -$0.10Est: -$0.10 | 0.0% | - | — | — |
| Apr 1, 2024 | Q4 2023 | -$0.09Est: -$0.12 | +25.0% | - | — | — |
| Nov 14, 2023 | Q3 2023 | -$0.07Est: -$0.09 | +22.2% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.09 | — | - | — | — |
| May 15, 2023 | Q1 2023 | -$0.08 | — | - | — | — |
| Mar 29, 2023 | Q4 2022 | -$0.08Est: -$0.11 | +27.3% | - | — | — |